Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$234.6B | 7.4 | 26.5% | 20.0% | 24.1% | 37.7% | 22.5% | (3.6%) | 3.9% | |
$781.6B | 6.9 | 40.7% | 33.2% | 1.4% | 74.1% | 28.5% | (5.7%) | 0.8% | |
$393.0B | 6.5 | 15.7% | 8.6% | 14.6% | 19.9% | 15.2% | (3.1%) | 3.6% | |
$369.2B | 6.1 | 8.3% | 1.8% | 15.2% | 90.3% | 9.9% | (3.4%) | 3.4% | |
$335.5B | 6.5 | 35.5% | 28.0% | 24.3% | 76.5% | 46.8% | (1.0%) | 2.8% | |
$230.3B | 6.9 | 15.4% | 7.2% | 13.4% | 20.1% | 10.8% | 94.5% | 2.0% | |
$220.7B | 7.1 | 17.7% | 10.8% | 18.7% | 27.3% | 17.5% | (4.9%) | 7.2% | |
$169.9B | 5.6 | 11.9% | 6.1% | 18.3% | 51.7% | 9.7% | (1.9%) | 2.8% | |
$148.1B | 6.0 | 9.0% | 17.0% | 5.9% | 8.9% | 8.6% | (2.3%) | 6.4% | |
$140.1B | 5.1 | 7.4% | 0.0% | (0.6%) | 2.9% | 6.4% | (3.0%) | 3.9% | |
$133.1B | 6.0 | 20.1% | 13.6% | 25.9% | (6.9%) | 18.1% | (4.0%) | 4.5% |
The Merck & Co., Inc. (MRK) ROIC is 26.5%, compared to the industry median of (14.7%) and the 5-year historical average of 15.0%.
The Merck & Co., Inc. (MRK) ROIC minus WACC is 20.0%, compared to the industry median of (8.6%) and the 5-year historical average of 9.6%.
The Merck & Co., Inc. (MRK) ROE is 37.7%, compared to the industry median of (20.1%) and the 5-year historical average of 26.5%.
The Merck & Co., Inc. (MRK) ROCE is 22.5%, compared to the industry median of (11.7%) and the 5-year historical average of 13.7%.